Multivariate analysis revealed that high MFAP2 expression was associated with low survival in patients with WHO G3/G4 glioma (Figures 7D,E), IDH-mutated glioma (Figures 7F,G) and non-codeletion glioma (Figures 7H,I). The gene discussed is MFAP2; the disease is central nervous system cancer.